Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Interplay between S-Glutathionylation and Phosphorylation of Cardiac Troponin I and Myosin Binding Protein C in End-Stage Human Failing Hearts.
Budde H, Hassoun R, Tangos M, Zhazykbayeva S, Herwig M, Varatnitskaya M, Sieme M, Delalat S, Sultana I, Kolijn D, Gömöri K, Jarkas M, Lódi M, Jaquet K, Kovács Á, Mannherz HG, Sequeira V, Mügge A, Leichert LI, Sossalla S, Hamdani N. Budde H, et al. Among authors: sossalla s. Antioxidants (Basel). 2021 Jul 16;10(7):1134. doi: 10.3390/antiox10071134. Antioxidants (Basel). 2021. PMID: 34356367 Free PMC article.
Empagliflozin directly improves diastolic function in human heart failure.
Pabel S, Wagner S, Bollenberg H, Bengel P, Kovács Á, Schach C, Tirilomis P, Mustroph J, Renner A, Gummert J, Fischer T, Van Linthout S, Tschöpe C, Streckfuss-Bömeke K, Hasenfuss G, Maier LS, Hamdani N, Sossalla S. Pabel S, et al. Among authors: sossalla s. Eur J Heart Fail. 2018 Dec;20(12):1690-1700. doi: 10.1002/ejhf.1328. Epub 2018 Oct 17. Eur J Heart Fail. 2018. PMID: 30328645 Free article.
Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation.
Kolijn D, Pabel S, Tian Y, Lódi M, Herwig M, Carrizzo A, Zhazykbayeva S, Kovács Á, Fülöp GÁ, Falcão-Pires I, Reusch PH, Linthout SV, Papp Z, van Heerebeek L, Vecchione C, Maier LS, Ciccarelli M, Tschöpe C, Mügge A, Bagi Z, Sossalla S, Hamdani N. Kolijn D, et al. Among authors: sossalla s. Cardiovasc Res. 2021 Jan 21;117(2):495-507. doi: 10.1093/cvr/cvaa123. Cardiovasc Res. 2021. PMID: 32396609
Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes.
Pabel S, Reetz F, Dybkova N, Shomroni O, Salinas G, Mustroph J, Hammer KP, Hasenfuss G, Hamdani N, Maier LS, Streckfuss-Bömeke K, Sossalla S. Pabel S, et al. Among authors: sossalla s. J Mol Med (Berl). 2020 Dec;98(12):1689-1700. doi: 10.1007/s00109-020-01989-6. Epub 2020 Oct 9. J Mol Med (Berl). 2020. PMID: 33034709 Free PMC article.
A mechanistic rationale for the investigation of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction. Letter regarding the article 'Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial'.
Pabel S, Hamdani N, Sossalla S. Pabel S, et al. Among authors: sossalla s. Eur J Heart Fail. 2021 May;23(5):841. doi: 10.1002/ejhf.2091. Epub 2021 Feb 4. Eur J Heart Fail. 2021. PMID: 33377246 Free article. No abstract available.
Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.
Hassoun R, Budde H, Zhazykbayeva S, Herwig M, Sieme M, Delalat S, Mostafi N, Gömöri K, Tangos M, Jarkas M, Pabel S, Bruckmüller S, Skrygan M, Lódi M, Jaquet K, Sequeira V, Gambichler T, Remedios CD, Kovács Á, Mannherz HG, Mügge A, Sossalla S, Hamdani N. Hassoun R, et al. Among authors: sossalla s. Int J Cardiol. 2021 Dec 1;344:160-169. doi: 10.1016/j.ijcard.2021.09.009. Epub 2021 Sep 10. Int J Cardiol. 2021. PMID: 34517018 Free article.
Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progression.
Hassoun R, Budde H, Zhazykbayeva S, Herwig M, Sieme M, Delalat S, Mostafi N, Gömöri K, Tangos M, Jarkas M, Pabel S, Bruckmüller S, Skrygan M, Lódi M, Jaquet K, Sequeira V, Gambichler T, Remedios CD, Kovács Á, Mannherz HG, Mügge A, Sossalla S, Hamdani N. Hassoun R, et al. Among authors: sossalla s. Int J Cardiol. 2022 Jan 15;347:44-45. doi: 10.1016/j.ijcard.2021.11.002. Epub 2021 Nov 10. Int J Cardiol. 2022. PMID: 34767897 No abstract available.
191 results